The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia)
Publications
Acute Eosinophilic Pneumonia Triggered by Carbamazepine Therapy: A Clinical and Radiologic Case Report.
Cureus 2026 May;18;e108598 — 2026 May
Carbamazepine-induced interstitial pneumonitis in a lung transplant patient.
Respiratory medicine 2006 Sep;100;1660-2 — 2006 Sep — 1660-2
[Acute eosinophilic pneumonia due to hypersensitivity to carbamazepine].
Revue des maladies respiratoires 1998 Dec;15;797-9 — 1998 Dec — 797-9
Pulmonary eosinophilia and asthma associated with carbamazepine.
British medical journal (Clinical research ed.) 1981 Feb 07;282;440 — 1981 Feb 07 — 440
Pulmonary eosinophilia associated with carbamazepine.
Archives of disease in childhood 1983 Oct;58;833-4 — 1983 Oct — 833-4
[Immuno-allergic side effects induced by the administration of carbamazepine. Case contribution].
Minerva medica 1984 Jun 30;75;1651-5 — 1984 Jun 30 — 1651-5
Carbamazepine and the lung.
The European respiratory journal 1990 Sep;3;930-1 — 1990 Sep — 930-1
Acute pulmonary hypersensitivity to carbamazepine.
Chest 1975 Oct;68;580-1 — 1975 Oct — 580-1
Acute hypersensitivity pneumonitis associated with carbamazepine therapy.
Chest 1978 Oct;74;463-4 — 1978 Oct — 463-4